European Medicines Agency approves Paxlovid, Pfizer's anti-Covid pill
Steph Deschamps / January 28, 2022
The European Medicines Agency (EMA) said Thursday it has approved Pfizer's anti-Covid pill, which becomes the first orally taken antiviral drug approved in the European Union.
The EMA recommended authorizing Paxlovid for the treatment of Covid-19 in adults who do not require supplemental oxygen and are at increased risk of the disease becoming severe, the European regulator said in a statement.
With the approval of Paxlovid this week, 6 anti-Covid drugs have been approved as part of the EU therapeutic strategy, European Commissioner for Health and Food Safety Stella Kyriakides welcomed in a statement.
The United States, Canada and Israel are among a handful of countries that have already given the green light to Pfizer's treatment.
Related Posts
New Zealander gets 10 Covid shots in ONE day: investigation launched
Steph Deschamps / December 11, 2021
New Zealand health authorities have launched an investigation after a man got th...
Read More
Vaccination for 5- to 11-year-olds: Italy gives green light to Pfizer vaccine
Sylvie Claire / December 2, 2021
Children aged 5 to 11 years will be able to receive one third of the dose given to...
Read More
Omicron variant poses very high risk globally, says WHO
Sylvie Claire / November 29, 2021
The new Omicron variant of the coronavirus presents a very high risk at the global...
Read More